Correlation Between Opthea and Oragenics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Opthea and Oragenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Oragenics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Oragenics, you can compare the effects of market volatilities on Opthea and Oragenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Oragenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Oragenics.

Diversification Opportunities for Opthea and Oragenics

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Opthea and Oragenics is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Oragenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oragenics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Oragenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oragenics has no effect on the direction of Opthea i.e., Opthea and Oragenics go up and down completely randomly.

Pair Corralation between Opthea and Oragenics

Considering the 90-day investment horizon Opthea is expected to under-perform the Oragenics. But the stock apears to be less risky and, when comparing its historical volatility, Opthea is 1.6 times less risky than Oragenics. The stock trades about -0.16 of its potential returns per unit of risk. The Oragenics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  31.00  in Oragenics on September 1, 2024 and sell it today you would earn a total of  1.00  from holding Oragenics or generate 3.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Opthea  vs.  Oragenics

 Performance 
       Timeline  
Opthea 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Opthea unveiled solid returns over the last few months and may actually be approaching a breakup point.
Oragenics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oragenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Opthea and Oragenics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Opthea and Oragenics

The main advantage of trading using opposite Opthea and Oragenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Oragenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will offset losses from the drop in Oragenics' long position.
The idea behind Opthea and Oragenics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios